Laakso M - Search Results

1

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trail Research Group. Chiasson JL, et al. Among authors: laakso m. Lancet. 2002 Jun 15;359(9323):2072-7. doi: 10.1016/S0140-6736(02)08905-5. Lancet. 2002. PMID: 12086760 Clinical Trial.

2

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Chiasson JL, et al. Among authors: laakso m. JAMA. 2003 Jul 23;290(4):486-94. doi: 10.1001/jama.290.4.486. JAMA. 2003. PMID: 12876091 Clinical Trial.

3

Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.

Temelkova-Kurktschiev T, Hanefeld M, Chinetti G, Zawadzki C, Haulon S, Kubaszek A, Koehler C, Leonhardt W, Staels B, Laakso M. Temelkova-Kurktschiev T, et al. Among authors: laakso m. J Clin Endocrinol Metab. 2004 Sep;89(9):4238-42. doi: 10.1210/jc.2003-032120. J Clin Endocrinol Metab. 2004. PMID: 15356014

4

The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Zacharova J, Chiasson JL, Laakso M; STOP-NIDDM Study Group. Zacharova J, et al. Among authors: laakso m. Diabetes. 2005 Mar;54(3):893-9. doi: 10.2337/diabetes.54.3.893. Diabetes. 2005. PMID: 15734870

5

Leptin receptor gene variation predicts weight change in subjects with impaired glucose tolerance.

Zacharova J, Chiasson JL, Laakso M. Zacharova J, et al. Among authors: laakso m. Obes Res. 2005 Mar;13(3):501-6. doi: 10.1038/oby.2005.52. Obes Res. 2005. PMID: 15833934 Free article. Clinical Trial.

6

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive Investigators. Dormandy JA, et al. Among authors: laakso m. Lancet. 2005 Oct 8;366(9493):1279-89. doi: 10.1016/S0140-6736(05)67528-9. Lancet. 2005. PMID: 16214598 Free article. Clinical Trial.

7

Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Andrulionyte L, Peltola P, Chiasson JL, Laakso M; STOP-NIDDM Study Group. Andrulionyte L, et al. Among authors: laakso m. Diabetes. 2006 Jul;55(7):2148-52. doi: 10.2337/db05-1629. Diabetes. 2006. PMID: 16804087

8

Single nucleotide polymorphisms of the HNF4alpha gene are associated with the conversion to type 2 diabetes mellitus: the STOP-NIDDM trial.

Andrulionyte L, Laukkanen O, Chiasson JL, Laakso M; STOP-NIDDM Study Group. Andrulionyte L, et al. Among authors: laakso m. J Mol Med (Berl). 2006 Aug;84(8):701-8. doi: 10.1007/s00109-006-0063-3. Epub 2006 Jul 13. J Mol Med (Berl). 2006. PMID: 16838170

9

Single nucleotide polymorphisms of the peroxisome proliferator-activated receptor-alpha gene (PPARA) influence the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial.

Andrulionyte L, Kuulasmaa T, Chiasson JL, Laakso M; STOP-NIDDM Study Group. Andrulionyte L, et al. Among authors: laakso m. Diabetes. 2007 Apr;56(4):1181-6. doi: 10.2337/db06-1110. Epub 2007 Feb 22. Diabetes. 2007. PMID: 17317762 Clinical Trial.

10

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.

Rajamani K, Colman PG, Li LP, Best JD, Voysey M, D'Emden MC, Laakso M, Baker JR, Keech AC; FIELD study investigators. Rajamani K, et al. Among authors: laakso m. Lancet. 2009 May 23;373(9677):1780-8. doi: 10.1016/S0140-6736(09)60698-X. Lancet. 2009. PMID: 19465233 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,395 results

Search Page

Filters